Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis.

Laura GragnaniSerena LoriniSilvia MarriUmberto BasileVeronica SantarlasciMonica MontiFrancesco MadiaLuisa PetracciaCristina StasiNiccolò MarelloCecilia NapodanoFrancesco AnnunziatoAnna Linda Zignego

Published in: Hepatology (Baltimore, Md.) (2021)

Hematological or genetic analyses could be used to foresee the CV clinical response after DAA therapy and could be valuable to assess a rational flowchart to manage CV during follow-up.

Keyphrases

genome wide
stem cells
hiv infected
antiretroviral therapy
dna methylation
cell therapy